Peripheral Neuropathy Trial, Recruiting NCT07057128 Sponsor: Izmir City Hospital Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07057128
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with subacromial pain syndrome (a common cause of shoulder pain) by a doctor
  • People who are 19 years of age or older
  • People who have had shoulder pain lasting at least 3 months
  • People whose shoulder pain has been rated at least 3 out of 10 on a pain scale over the past week
  • People who test positive on three specific physical shoulder examinations carried out by a clinician (confirm with trial site for details on these tests)

Who may not be able to join:

  • People with a history of inflammatory disease affecting the shoulder joint (such as rheumatoid arthritis)
  • People with a history of neurological disorders
  • People who have previously had surgery on the shoulder
  • People who test positive on a physical test called the "drop arm test"
  • People who have reduced passive movement in the shoulder (where a clinician cannot move the shoulder through its normal range)
  • People who have measurable loss of muscle strength
  • People whose imaging results (such as an X-ray or MRI) have confirmed a specific structural problem in the shoulder
  • People with a full tear of the rotator cuff (the group of muscles and tendons stabilising the shoulder)
  • People with nerve-related symptoms or deficits in the arm or hand
  • People who have been diagnosed with cancer or have an active infection
  • People who have taken medication for nerve pain for any reason within the past 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Izmir City Hospital
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
26 March 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Hyperalgesia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov